Načítá se...
Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod
Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system, traditionally considered to be an autoimmune, demyelinating disease. Based on this understanding, initial therapeutic strategies were directed at immune modulation and inflammation control. At present, there ar...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3590932/ https://ncbi.nlm.nih.gov/pubmed/23483794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S17426 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|